CN104043084B - 细胞美容制剂 - Google Patents
细胞美容制剂 Download PDFInfo
- Publication number
- CN104043084B CN104043084B CN201410281185.8A CN201410281185A CN104043084B CN 104043084 B CN104043084 B CN 104043084B CN 201410281185 A CN201410281185 A CN 201410281185A CN 104043084 B CN104043084 B CN 104043084B
- Authority
- CN
- China
- Prior art keywords
- cell
- blood
- preparation
- effects
- ant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title abstract description 17
- 239000000203 mixture Substances 0.000 title abstract description 12
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 18
- 230000003796 beauty Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 6
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 65
- 210000004369 blood Anatomy 0.000 abstract description 33
- 239000008280 blood Substances 0.000 abstract description 33
- 239000000843 powder Substances 0.000 abstract description 16
- 206010016256 fatigue Diseases 0.000 abstract description 15
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract description 13
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract description 13
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 235000013399 edible fruits Nutrition 0.000 abstract description 12
- 208000037259 Amyloid Plaque Diseases 0.000 abstract description 11
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 9
- 206010008570 Chloasma Diseases 0.000 abstract description 9
- 208000003351 Melanosis Diseases 0.000 abstract description 9
- 206010000496 acne Diseases 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 201000004681 Psoriasis Diseases 0.000 abstract description 7
- 201000004384 Alopecia Diseases 0.000 abstract description 5
- 231100000360 alopecia Toxicity 0.000 abstract description 5
- 206010020850 Hyperthyroidism Diseases 0.000 abstract description 4
- 239000000049 pigment Substances 0.000 abstract description 4
- 208000002381 Brain Hypoxia Diseases 0.000 abstract description 3
- 208000007502 anemia Diseases 0.000 abstract description 3
- 230000002490 cerebral effect Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000037303 wrinkles Effects 0.000 abstract description 3
- 230000001900 immune effect Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 101100037618 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ant-1 gene Proteins 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 230000032677 cell aging Effects 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 51
- 230000001737 promoting effect Effects 0.000 description 21
- 230000005906 menstruation Effects 0.000 description 20
- 230000001815 facial effect Effects 0.000 description 16
- 239000003814 drug Substances 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 15
- 229940038481 bee pollen Drugs 0.000 description 14
- 208000011580 syndromic disease Diseases 0.000 description 14
- 230000001976 improved effect Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 241000207925 Leonurus Species 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- 230000001105 regulatory effect Effects 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 244000241838 Lycium barbarum Species 0.000 description 11
- 235000015459 Lycium barbarum Nutrition 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 230000036039 immunity Effects 0.000 description 10
- 241000257303 Hymenoptera Species 0.000 description 9
- 208000037093 Menstruation Disturbances Diseases 0.000 description 8
- 206010027339 Menstruation irregular Diseases 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 244000061520 Angelica archangelica Species 0.000 description 7
- 235000001287 Guettarda speciosa Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 241000382455 Angelica sinensis Species 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 206010046798 Uterine leiomyoma Diseases 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000001914 calming effect Effects 0.000 description 5
- 208000017520 skin disease Diseases 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 206010006895 Cachexia Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000026500 emaciation Diseases 0.000 description 4
- 230000002996 emotional effect Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 208000026278 immune system disease Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000036651 mood Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010054196 Affect lability Diseases 0.000 description 3
- 206010048768 Dermatosis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000007969 cellular immunity Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 208000025661 ovarian cyst Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000010183 Thymus Hyperplasia Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 230000002989 hypothyroidism Effects 0.000 description 2
- 208000003532 hypothyroidism Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 206010024380 Leukoderma Diseases 0.000 description 1
- 206010025280 Lymphocytosis Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 241000802381 Polyrhachis vicina Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 241001620634 Roger Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000007501 Thymosin Human genes 0.000 description 1
- 108010046075 Thymosin Proteins 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241001521901 Tribulus lanuginosus Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 208000001936 exophthalmos Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 238000011502 immune monitoring Methods 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- YTSPICCNZMNDQT-UHFFFAOYSA-M tibezonium iodide Chemical compound [I-].C1C(SCC[N+](C)(CC)CC)=NC2=CC=CC=C2N=C1C(C=C1)=CC=C1SC1=CC=CC=C1 YTSPICCNZMNDQT-UHFFFAOYSA-M 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种细胞美容制剂,要解决的技术问题治疗黄褐斑、老年斑、色斑、粉刺、脱发、牛皮癣、白癜风、甲亢、甲减及体弱寒湿所致的妇科病症和气血不足、免疫功能低下、脑贫血、脑缺氧、疲劳及更年期综合症。本由以下质量比组分的原料制成:蚂蚁1‑6000,珍珠粉1‑3500,益母草1‑2000,当归1‑1500,蜂花粉1‑2500,枸杞子1‑3000。本发明与现有技术相比,通过补肾填精、益气养血,疏通经络,向人体组织细胞提供必须的充足生命物质,保证细胞结构的完整性和新陈代谢的正常进行,使组织细胞充满青春活力,延缓细胞衰老过程,解决由于细胞不能进行正常生命活动而导致的皱纹,色素,记忆衰退,精力不足。
Description
技术领域
本发明涉及一种细胞美容制剂,特别是一种治疗黄褐斑、老年斑、色斑、粉刺、牛皮癣、白癜风、甲亢、甲减、气血虚亏、免疫功能失调和各种疲劳及更年期综合症、月经不调、子宫肌瘤等的细胞美容制剂。
背景技术
祖国医学有“盖有诸内者,必形诸外”的诊断,把面部及身体皮肤作为五脏的镜子提出了健美的人体要适应四时自然地变化的“天人合一”思想。所以美容是一个从美的吸收到美的释放再到美的吸收的循环往复过程,是在健康的基础上的内在美与外在美的有机结合。现代社会由于生活环境,自然环境,饮食等原因,导致许多人机体功能异常,细胞代谢功能减退,衰老症状过早出现。具体表现为:损容性皮肤病如斑、癣、过敏,脑缺氧,脑贫血,疲劳及更年期综合症、免疫功能失调及妇科病症等。现今,市面上一些据称在美容方面细胞注射疗法如羊胎素等的产品,虽能见效快,但易产生依赖性,易引起皮肤细胞功能下降、皮肤萎缩变薄、对外界抵抗力下降、敏感等激素样副作用。对于其它由于工作压力大等引起的疲劳综合症,目前也没有从根本上解决的措施。
发明内容
本发明的目的是提供一种细胞美容制剂,要解决的技术问题治疗黄褐斑、老年斑、色斑、粉刺、脱发、牛皮癣、白癜风、甲亢、甲减及体弱寒湿所致的妇科病症和各种原因引起的气血不足、免疫功能低下、脑贫血、脑缺氧、疲劳及更年期综合症。
本发明采用以下技术方案:一种细胞美容制剂,由以下质量比组分的原料制成:
本发明的细胞美容制剂由以下质量比组分的原料制成:
本发明的细胞美容制剂由以下质量比组分的原料制成:
本发明的细胞美容制剂由以下质量比组分的原料制成:
蚂蚁 2—15000, 珍珠粉 1—10000, 益母草 1—8000,
当归 1—6000, 蜂花粉 1—7000, 枸杞子 1—10000。
本发明的细胞美容制剂由以下质量比组分的原料制成:
蚂蚁 10—5000, 珍珠粉 5—3500, 益母草 2—2500,
当归 5—3000, 蜂花粉 3—3000, 枸杞子 3—3000。
本发明的细胞美容制剂由以下质量比组分的原料制成:
蚂蚁 152, 珍珠粉 45, 益母草 35,
当归 30, 蜂花粉 20, 枸杞子 35。
本发明与现有技术相比,通过补肾填精、益气养血,疏通经络,调补冲任达到细胞美容即美容美发及治疗体弱寒湿所致的妇科病症的目的,通过对细胞进行美容,向人体组织细胞提供必须的充足生命物质,保证细胞结构的完整性和新陈代谢的正常进行,使组织细胞充满青春气息,青春活力,延缓细胞衰老过程,从根本上解决由于细胞不能进行正常生命活动而导致的皱纹,色素,记忆衰退,精力不足等,这与常规活血化瘀、改善微循环、调节内分泌制剂有本质的不同,本发明以拟多刺蚂蚁为主要原料,通过增大胸腺双向调节免疫力,彻底改善内分泌,活化免疫细胞,提高免疫力。同时,本专利可将锌变为活性使其更易被吸收利用,而锌是多种酶的组分,具有促进组织再生,提高免疫力,保护皮肤健康的作用;还含有丰富的锰可提高中、老年人超氧化物歧化酶活性,增强其抗氧化活性,防止自由基对机体的损伤,具有美容、抗老化、抗过敏等全能的功效。
具体实施方式
下面结合实施例对本发明作进一步详细说明。
本发明的细胞美容制剂,以克为单位,由以下质量比组分的制成:
优选质量比组分组成:
最佳质量比组分组成:
本发明的细胞美容制剂,特别是治疗黄褐斑、老年斑、气血亏虚和疲劳及更年期综合症等的细胞美容制剂,以克为单位,由以下质量比组分组成:
蚂蚁 2—15000, 珍珠粉 1—10000, 益母草 1—8000,
当归 1—6000, 蜂花粉 1—7000, 枸杞子 1—10000。
优选质量比组分组成:
蚂蚁 10—5000, 珍珠粉 5—3500, 益母草 2—2500,
当归 5—3000, 蜂花粉 3—3000, 枸杞子 3—3000。
最佳质量比组分组成:
蚂蚁 152, 珍珠粉 45, 益母草 35,
当归 30, 蜂花粉 20, 枸杞子 35。
本发明的细胞美容制剂中,所采用的各味中药的功效和作用:
蚂蚁,具有滋补肝肾,益气养血、填精壮阳、强筋健骨、祛风通络的作用,明代李时珍《本草纲目》一文中记载:蚂蚁处处有之……其卵名蚔,山人掘之,古人食之,故内则。天官馈食之豆有醢也:凡人食之,益气泽颜.染者食之而愈也。经药理研究实验证明,蚂蚁提取液是一广谱的免疫机能增强剂。突出表现为能使老龄鼠血液白细胞和溶菌酶增加,提高巨噬细胞吞噬功能,从而促进了非特异性免疫防御体系的作用;能提高抗原触发后特异性抗体生成细胞的数量和血清抗体水平;同时能使EaRFC、E1RFC、ANAE阳性细胞及淋巴细胞绝对值升高,可以看出蚁液又是一种细胞免疫兴奋剂。胸腺退化及由此而造成的细胞免疫机能低下、免疫调控和免疫监视机能衰退,是衰老和感染、肿瘤、自身免疫性疾病发生的根源。而蚁液可以使老龄鼠已趋退化的胸腺增生、重量增加、皮质区淋巴细胞增多,并使外周血淋巴细胞内DNA、RNA含量和母化细胞率增高,这是蚁液直接促进免疫中枢功能活化的结果。注射蚁液组老龄鼠血液和免疫器官的Mn、Se、Zn含量明显上升,而CU、FE含量降低,这种改变也是抗衰老、增强免疫的重要原因之一。蚂蚁能提高红细胞活力,降低血脂、促进免疫功能,起到护肝、镇静、抗炎、镇痛和解痉平喘的作用。蚂蚁体内含有苏氨酸、苯丙氨酸、缬氨酸、蛋氨酸、赖氨酸等19种氨基酸,其中包括人体必需的8种氨基酸,蛋白质含量高达40—60%;并含有维生素B1、B2、B3、C、D、E等;微量元素含有锌、铁、硒、磷、钙等28种,其中14种为人体所需,尤其锌、硒(生命之花、免疫之本)含量最丰富,比自然界任何食品高10—20倍,还含有柠檬(C10H14O)、蚁醛(HCHO)、胸蚁醛(C10H14O)柠檬醛等特殊类化合物;还含有ATP、多种酶和辅酸、生物碱、组织胺等生物活性物质;此外还有特殊的(蚂蚁抗生素)即后胸侧极腺素等特种抗菌素,因此号称微动物营养宝库。
珍珠粉,具有平肝、潜阳、定惊、止血功效,能影响甲状腺代谢,改善机体免疫功能。
益母草,具有活血祛瘀、调经利尿、清热解毒功效。药理和临床证明:益母草对皮肤真菌的生长有抑制作用。对月经不调、气滞血瘀等有较好的疗效。
当归,具有补肾益精、益气养血、调经止痛功效。
蜂花粉,具有益气养血、滋补强壮、安神益智、延寿驻颜功效。研究表明:常服蜂花粉可促进发育,消除疲劳,增强智力,延年益寿,滋润皮肤,消除色斑、皱纹。
枸杞子,具有补益肝肾、养血明目功效。
生地,具有清热,凉血,生津,养阴功效。
大黄,具有泻下攻积、清热泻火、凉血解毒、逐瘀通经、荡涤肠胃、推陈出新、调中化食、安和五脏功效。
郁金,具有活血止痛、行气解郁、凉血清心、利胆退黄功效。
玉竹,具有补诸不足、养阴润燥、滋养气血、生津止渴、健脾润肺、轻身延年功效。玉竹为阴阳双补之要药,其中所含维生素A能改善干裂、粗糙的皮肤状况,使之柔软润滑,起到美容护肤的作用。
白芷,具有祛风解表,消肿止痛,燥湿止带功效。
香菇,具有益气健脾、利肝益胃、理气化痰的功效。
红花,具有活血祛瘀、解毒止痛功效。治疗溃疡病、压疮、湿疹效果显著。
麦芽,具有行气消食、健脾和胃、疏肝行气功效。
蜂胶,具有润肤生肌、消炎止痛、排除毒素、净化血液、强化免疫功效。对治疗皮肤瘙痒、带状疱疹及各类炎症有显著疗效。
人参,具有大补元气、固脱生津、安神益智、强精通脉、延缓衰老功效。药理和临床研究表明:人参所含的麦芽醇具有抗氧化活性,它可与机体内的自由基结合,从而减少脂褐素在体内的沉积。可以改善色素沉着、脱发等,起到美容驻颜作用。
菊花,具有散风清热、平肝明目、调利血脉功效。
虫草,具有秘精益气、补肺益肾、止血化痰功效。
浮萍,具有发汗解表、透疹、祛风止痒、利水消肿功效。
牡蛎,具有重镇安神、潜阳补阴、软坚散结、收敛固涩的功效。其擅长平秘阴阳,含有丰富的钙、锌等微量元素,对养颜美容有一定作用。
乌梅,具有敛肺、涩肠、生津、安蛔、止血功效。
黄精,具有宽中益气、益肾填精、滋阴润肺、强筋壮骨、调和五脏、轻身延年功效。临床研究表明:黄精对细胞免疫、体液免疫有一定影响,能提高淋巴细胞转化率,有利于抗体的形成。并含有抗菌物质,对红色表皮癣菌等多种真菌有抑制作用。
首乌,具有养血祛风、黑发轻身、延年耐寒、润肠通便、解毒清湿热功效。
薄荷,具有疏散风热、清利头目、利咽、透疹功效。
干姜,具有止呕和胃,化饮祛痰,发表散寒,解毒除臭功效。其含有强心、健胃、抗炎、健脑等生物活性物质,内服外用、疗身健体皆良。
柴胡,具有发表和里、解肌生阳、退热、解郁调经功效。柴胡为舒肝解郁、宣扬气血的要药,药理和临床研究表明:其具有抗炎、镇静、增强体液和细胞免疫的作用。
白僵蚕,具有祛风解痉、化痰散结功效。《神农本草经》:“去三虫,灭黑皯,令人面色好。”
白芍,具有养血敛阴、柔肝止痛、善平肝阳功效。现代药理研究表明,白芍具有解痉、镇静、抗溃疡、保肝、抗炎、抗病毒、解热等作用。
白蒺藜,具有平肝疏肝、祛风明目、清热解毒功效。主治白癜风、疣、敏感等。
蜂蜜,具有补虚、润燥、解毒、滑肠、止咳、止痛、调和诸药。药理和临床研究表明,蜂蜜可调节体内酸碱平衡,提高人体抵抗能力,也是较强的抗霉菌剂,可内服或外用治疗各种炎症、创伤。
损容性皮肤病如黄褐斑、老年斑、色斑、牛皮癣、白癜风等和部分妇科病如月经不调、疲劳及更年期综合症、气血亏虚、免疫功能失调及追根溯源皆因机体细胞外环境改变,导致细胞不能进行正常生命活动所致。现代医学研究证明:蚂蚁是一广谱免疫机能增强剂即细胞免疫兴奋剂,可以激发细胞活力,蚂蚁作为血肉有情之品,具有补精益气、填髓、调补冲任的功效,可使已退化的胸腺增生,增加胸腺素分泌,从而使内分泌腺体趋于正常,而且蚂蚁含有多种活性微量元素,可使损伤的细胞再生,萎缩的细胞得到修复。蚂蚁与其它29味中药配伍应用,起到综合调理以治疗细胞功能异常引起损容性皮肤病及妇科疾病的目的,且长期服用无副作用。以蚂蚁血肉有情之品的动物药中药为主配,以扶正祛邪的珍珠粉、益母草、当归、蜂花粉、枸杞子共6味药组成的经典组方对损容性皮肤病和部分妇科病,如黄褐斑、老年斑、色斑、粉刺、牛皮癣、白癜风、气血亏虚、疲劳及更年期综合症及月经不调、免疫功能失调等即治标又治本,临床上已取得了十分理想的效果。
本发明的细胞美容制剂,可用以下方法制备得到:按质量比,将以上各味中药分别加10、8、6倍量的水煎煮3次,第一次2小时,第二次1.5小时,第三次1小时,合并煎液,滤过、减压浓缩至60℃时相对密度为1.18—1.20的浸膏,得到本发明的细胞美容制剂。
按质量比,每100㎏浸膏加65㎏水溶解、过滤,制成液体,得到治疗细胞美容制剂口服液。
在浸膏内加入90%-98%乙醇至乙醇浓度为60%,放置不少于12小时,吸出上清液,醇沉混悬液离心,合并乙醇溶液,减压回收乙醇,浓缩至60℃相对密度1.10-1.14,干燥或浸膏干燥,制成颗粒,分装成袋装冲剂;或干燥后压成片剂,每片0.3-0.5克;或干燥后加植物油装入胶囊,每粒胶囊重0.2-0.5克,制成软胶囊,或直接装入胶囊,得到细胞美容制剂冲剂、片剂、胶囊。
本发明的细胞美容制剂口服液,为液态,棕褐色,气微香、味微甘、微酸,无异味,供口服,用温开水送服,每日3次,每次10-30毫升,3个月为一个疗程,也可外用涂患处一日一次,1个月为一个疗程。
本发明的细胞美容制剂冲剂,为颗粒状,棕色,气清香、味微苦,用温开水冲服,每日3次,每次3-10克,3个月一个疗程。
本发明的细胞美容制剂片剂,棕色,气清香、味微苦,用温开水送服,每日3次,每次2-4片,3个月为一个疗程。
本发明的细胞美容制剂胶囊剂,棕色,气清香、味微苦,用温开水送服,每日3次,每次2—4粒,3个月为一个疗程。
实施例1,单位为克,细胞美容制剂的组分组成为,
实施例2,单位为克,细胞美容制剂的组分组成为,
实施例3,单位为克,细胞美容制剂的组分组成为,
实施例4,单位为克,细胞美容制剂的组分组成为,
实施例5,单位为克,细胞美容制剂的组分组成为,
实施例6,单位为克,细胞美容制剂的组分组成为,
蚂蚁 2, 珍珠粉 1, 益母草 1,
当归 1, 蜂花粉 1, 枸杞子 1。
实施例7,单位为克,细胞美容制剂的组分组成为,
蚂蚁 15000, 珍珠粉 10000, 益母草 8000,
当归 6000, 蜂花粉 7000, 枸杞子 10000。
实施例8,单位为克,细胞美容制剂的组分组成为,
蚂蚁 10, 珍珠粉 5, 益母草 2,
当归 5, 蜂花粉 3, 枸杞子 3。
实施例9,单位为克,细胞美容制剂的组分组成为,
蚂蚁 5000, 珍珠粉 3500, 益母草 2500,
当归 3000, 蜂花粉 3000, 枸杞子 3000。
实施例10,单位为克,细胞美容制剂的组分组成为,
蚂蚁 152, 珍珠粉 45, 益母草 35,
当归 30, 蜂花粉 20, 枸杞子 35。
治疗例1,王某某,女,32岁,上海人,面部蝴蝶斑。患者从26岁开始,脸上出现色素斑,开始色浅,面部和鼻二侧都有,用护肤品和到医院用中西药物治疗,效果不好,特别是鼻二侧皮肤色斑不断变大,颜色不断加深,医院诊断为“面部蝴蝶斑”,同时月经周期不规律时前时后,经量时多时少,痛经,久治不愈。患者十分苦脑。服用细胞美容制剂实施例1口服液,服用一个月后,面部色斑颜色开始变淡,服用二个月后,“面部蝴蝶斑”消失,月经恢复正常。
治疗例2,张某,女,48岁,黑龙江人,更年期综合症。患者43岁开始,月经变得不规律,有时提前,有时推迟;45岁开始,月经量开始时多时少,同时出现多汗,失眠,乏力,老年斑,进而出现情绪不稳,时而情绪激动,时而情绪低落,甚至多疑易怒,到多家医院诊治,反复检查,未发现器质性病变,诊断为更年期综合症。服药无效;46岁以后,几乎停经,2-3月来一次月经,量少色暗。情绪更加不稳,食欲减退,消化不良,消瘦。经朋友介绍服用细胞美容制剂实施例2胶囊剂,服药一个月后,疲乏无力的症状开始减轻,服用二个月,月经开始恢复,又坚持服用三个月,月经基本恢复正常。老年斑,多汗,失眠,乏力消失,情绪特好。
治疗例3黎某,女,39岁,职业,行政经理,河南人。从2008年初开始出现月经紊乱,表现为月经时前时后,经量渐少,色淡。面部色斑增多,同时常感乏力工作能力下降,多处求医,服大量中药和西药,但效果不好,且症状越来越重,2010年下半年,在医院检查发现卵巢减退,继续用西药治疗,效果仍然不好,病情反复且一步步加重,月经完全没了,还常出现下腹不适等症。2010年底,开始服用细胞美容制剂实施例3口服液一个月后,感觉病情在开始好转了,开始是面部色班明显变淡。服用三个月,2011年3月初开始,月经渐渐恢复正常了,面部色斑基本消失,精力和体力基本恢复正常。
治疗例4,赵某某,女,36岁,石家庄人,甲亢,消瘦,情绪易激动,黄褐斑,子宫肌瘤。患者32岁时,开始出现痛经,服药无效,33岁时出现月经紊乱,经量时多时少,经期明显延长,经多家妇科医院专家诊治,症状越来越重,病人一度失去治疗信心;35岁时再次就诊,经B超检查发现子宫前壁有一直径5cm肿块,诊断为“子宫肌瘤”,因拒绝手术治疗,服用细胞美容制剂实施例4口服液,一个半月左右,阴道出血基本停止,子宫肌瘤开始缩小。继续服用至五个月后,子宫肌瘤消失,子宫恢复正常大小,月经恢复正常,黄褐斑消失,情绪好转,体重增加至正常。
治疗例5,肖某,女,32岁,北京人,牛皮癣,甲减,卵巢囊肿。患者长期皮肤脱屑,瘙痒,抓后出血,易疲劳,整天无精打彩,月经不准,医院检查T3、T4、甲状腺素指标低下,28岁结婚,婚后,痛经加重。并出现月经不调,经常下腹不适,30岁时发生“功能性子宫出血”一次。经医院B超检查右侧“卵巢囊肿”,结婚四年未孕。服用细胞美容制剂实施例5口服液三个月,复查B超发现“卵巢囊肿”缩小一半;皮肤瘙痒减轻,精神好转;继续服用至第七个月时,B超检查,双侧卵巢大小正常。皮屑消失,无痒,精力充沛,医院检查T3、T4、甲状腺素指标正常,月经正常。
治疗例6,李某某,女,28岁,香港人,面部痤疮三年。患者从25岁开始,面部开始长“痘”,开始只有数个散在出现在面部二侧,后来“痘”越来越多,到医院看后服药无效,又买了很多治“痘”的“特效药”,外用内服的都有,但就是不见效,还常“痘”周发红,“痘”出脓点。用怀疑的心情服用细胞美容制剂实施例6冲剂,服药半月开始,“痘”开始变小了,坚持服用二个月时,面部痤疮基本消退,又坚持服用一月,面部光洁如常。
治疗例7,李某某,女,24岁,新加坡人,面部色斑、粉刺,脱发较重2年余。经前乳房胀痛,经来小腹坠胀,有血块,易怒,消瘦,轻度突眼。经多方医治效果不佳,服用细胞美容制剂实施例7片剂,一个月后症状减轻,二个月基本消失,半年完全消失。
治疗例8,林某,女,47岁,福建人。脸上不知不觉长出许多老年斑,睡眠质量差,苍老。到多家美容院做过皮肤护理,效果不明显。服用细胞美容制剂实施例8胶囊剂,第3周睡眠质量改善,面部斑色变浅,三个月后老年斑基本消失,并显得格外年轻。
治疗例9祁某,女,36岁,长沙人,25岁开始,面色苍白,整天少气无力,活动出汗,睡眠差,脱发明显,未予以治疗;28岁以后,活动气喘,面部色斑增加颜色加深,同时出现胸胁胀痛,情绪烦燥等不适,经多家医院诊治,虽胸胀稍减,但面部色斑仍在增多加深,30岁开始服用细胞美容制剂实施例9片剂四个月后,面部气色有红润,色斑开始渐渐变淡,继续服用至六个月后,面部气色光亮,色斑及各种症状消失。
治疗例10方某,女,42岁,沈阳人,面部色斑10年,开始色淡,未重视,36岁开始,面部色斑色渐加深,38岁开始出现心情烦燥,消瘦,大便次数多,心跳快100次/分左右,情绪不稳,月经不调等症,在医院治疗效果不好;39岁时开始服用细胞美容制剂实施例10冲剂五个月后,面部色斑消退,心情恢复正常,体重增加,大便正常,心率60-70次/分,月经恢复正常,其他症状也同时消失。
治疗例11王某,女,52岁,广州人,经常头晕,眼花,睡眠差,近1年来月经有时2-3个月来一次,多疑,忽冷忽热,有时手脚麻木,老年斑以面部、手背为多,心烦易怒,大便时干时稀,多方求医无果,听人介绍服用细胞美容制剂实施例6胶囊剂3个月各种症状减轻,半年后老年斑及各种症状消失,现与常人。
治疗例12刘某,女,67岁,西安人,从60岁开始全身出老年斑以面手背暴露部位多,手指早缰硬活动后好转,怕冷,易疲劳,多家医院治疗无效果。自己外孙女因服用细胞美容制剂实施例7冲剂治疗红斑狼疮8个月好了,逐将剩下一些给自己服用,效果十分明显,逐又连服3个月,各种症状明显好转,半年后各种症状完全消失。
治疗例13,女,18岁,重庆人,粉刺从12岁来月经开始就有,并逐渐加重,月经量少,头发干燥无光泽,易疲劳,多方治疗无效,服用细胞美容制剂实施例5冲剂15天好转,3个月完全好了。
本发明以蚂蚁为主要原材料配以动植物药材,具有补肾填精、益气养血,疏通经络,调补冲任的功效。是广谱免疫机能增强剂,能从五脏六腑、气血、精神整体调理如神经、免疫、内分泌及组织细胞等。通过增大胸腺双向调节免疫力彻底改善内分泌。本发明与传统的蚂蚁酒、蚂蚁粉、蚂蚁口服液相比,不仅保留了蚂蚁的全部有效成分及活性物质,且以酶的形式直接吸收利用,使吸收利用率从20%提高到80%以上,同时本发明所含的活性锌、锰是损容性损容性皮肤病有益的必需微量元素,并含有多种多样的活性物及营养类物质,对湿疹、黑斑,带状疱疹等也有极佳效果。
本发明在治疗损容性皮肤病和妇科病,特别是治疗黄褐斑、粉刺、牛皮癣、白癜风、气血亏虚、疲劳及更年期综合症及月经不调等具有标本兼治的理想效果,而且原料易得,成本低,无毒副作用,见效快,并治愈后不复发。
用本发明的细胞美容液制剂来治疗损容性皮肤病和部分妇科病,是一种简单、安全、疗效可靠地治疗方法,但是损容性皮肤病和部分妇科病多数是系统性疾病,必须按疗程服用,才能达到综合治疗的目的。
Claims (1)
1.一种细胞美容口服制剂,其特征在于:所述细胞美容口服制剂由以下质量比组分的原料制成:
所述的细胞美容口服制剂,可用以下方法制备得到:按质量比,将以上各味中药分别加10、8、6倍量的水煎煮3次,第一次2小时,第二次1.5小时,第三次1小时,合并煎液,滤过、减压浓缩至60℃时相对密度为1.18—1.20的浸膏,每100㎏浸膏加65㎏水溶解、过滤,制成液体,得到治疗细胞美容制剂口服液;
或者,
在浸膏内加入90%-98%乙醇至乙醇浓度为60%,放置不少于12小时,吸出上清液,醇沉混悬液离心,合并乙醇溶液,减压回收乙醇,浓缩至60℃相对密度1.10-1.14,干燥或浸膏干燥,制成颗粒,分装成袋装冲剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410281185.8A CN104043084B (zh) | 2014-06-20 | 2014-06-20 | 细胞美容制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410281185.8A CN104043084B (zh) | 2014-06-20 | 2014-06-20 | 细胞美容制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104043084A CN104043084A (zh) | 2014-09-17 |
CN104043084B true CN104043084B (zh) | 2017-09-01 |
Family
ID=51496806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410281185.8A Active CN104043084B (zh) | 2014-06-20 | 2014-06-20 | 细胞美容制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104043084B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105166886A (zh) * | 2015-08-14 | 2015-12-23 | 殷永洲 | 一种美容养颜的养生冲剂 |
CN107319559A (zh) * | 2017-08-09 | 2017-11-07 | 吉林青晨药业有限公司 | 一种具有祛黄褐斑功能性健康产品的制备技术 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113753A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 祛斑美容制剂 |
CN101095751A (zh) * | 2006-12-15 | 2008-01-02 | 甘肃奇正藏药有限公司 | 具有祛黄褐斑、改善营养性贫血的药物组合物及制备方法 |
CN102772704A (zh) * | 2012-08-15 | 2012-11-14 | 殷广全 | 老年病药物 |
-
2014
- 2014-06-20 CN CN201410281185.8A patent/CN104043084B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113753A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 祛斑美容制剂 |
CN101095751A (zh) * | 2006-12-15 | 2008-01-02 | 甘肃奇正藏药有限公司 | 具有祛黄褐斑、改善营养性贫血的药物组合物及制备方法 |
CN102772704A (zh) * | 2012-08-15 | 2012-11-14 | 殷广全 | 老年病药物 |
Also Published As
Publication number | Publication date |
---|---|
CN104043084A (zh) | 2014-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102078520B (zh) | 一种治疗神经性头痛的中药制剂及其制备方法 | |
CN102091258B (zh) | 一种祛除疤痕的中药组合物及其制备方法 | |
CN1245187C (zh) | 一种治疗由脏腑病所致眼病的药物 | |
CN103432475A (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN103320295A (zh) | 一种配制酒 | |
CN104043084B (zh) | 细胞美容制剂 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN104740583A (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
CN104274754A (zh) | 一种治疗小儿遗尿的中药组合物及其制备方法 | |
CN105920269A (zh) | 一种女性保健药酒 | |
CN104940725A (zh) | 一种养血美容的铁皮石斛中药组合物及其制剂 | |
CN101912523A (zh) | 一种治疗小儿缺铁性贫血症的中药制剂 | |
CN101062335B (zh) | 一种祛黄褐斑的保健品 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN102552519A (zh) | 一种活血止痛中药组合物及制备工艺和应用 | |
CN112138126A (zh) | 一种有效缓解痛经的组合物及其制备方法 | |
CN1517115A (zh) | 治疗慢性盆腔炎的中成药——妇炎胶囊 | |
CN105267711A (zh) | 一种用于治疗眩晕症的药物制剂 | |
CN104524479A (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
CN101530552A (zh) | 一种用于治疗血虚证的中药组合及其制备方法 | |
CN104398789A (zh) | 一种治疗缺铁性贫血的中药汤剂 | |
CN112675264B (zh) | 治疗银屑病的组合物、制备方法及其应用 | |
CN102416134B (zh) | 一种治疗小儿智力低下的药物及制备方法 | |
CN102764383B (zh) | 一种治疗产后乳头皲裂的乳头护理液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200323 Address after: No. 28, Zhonghao 2nd Road, Bantian street, Longgang District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Riyueshen Biotechnology Co.,Ltd. Address before: 518049 Guangdong city of Shenzhen province Futian District Whampoa court Cui you yuan 6-21B Patentee before: Yin Guangquan |
|
TR01 | Transfer of patent right |